Immatics (IMTX) Exchange Rate Effect (2019 - 2025)
Immatics (IMTX) posted Exchange Rate Effect of -$1.1 million for Q4 2025, down 190.27% sequentially from $1.3 million in Q3 2025, and down 114.94% YoY from $7.6 million in Q4 2024.
Immatics (IMTX) Exchange Rate Effect (2019 - 2025) Analysis & Trends
Immatics has reported Exchange Rate Effect for 7 years, with the latest figure at -$1.1 million in Q4 2025.
- Quarterly Exchange Rate Effect fell 114.94% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.0 million (down 286.96% YoY) and the FY2025 annual result came in at -$18.5 million, down 289.38% from the prior year.
- Exchange Rate Effect retreated to -$1.1 million in Q4 2025 per IMTX's latest filing, from $1.3 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $8.4 million in Q2 2022 and troughed at -$13.6 million in Q4 2022.
- A 5-year average of -$370.13 and a median of -$277741.9 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2021 and 2025: Exchange Rate Effect soared 1857.76% in 2021, then sank 102108.37% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$712693.9 in 2021, then plunged by 1813.25% to -$13.6 million in 2022, then soared by 88.84% to -$1.5 million in 2023, then surged by 596.73% to $7.6 million in 2024, then plunged by 114.94% to -$1.1 million in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.1 million, $1.3 million, and -$12.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | -1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | -12.08 Mn |
| Jun 30, 2025 | -12.08 Mn |
| Mar 31, 2025 | -6.07 Mn |
| Mar 31, 2025 | -6.07 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | -1.62 Mn |
| Sep 30, 2024 | -1.62 Mn |
| Jun 30, 2024 | 11,845.76 |
| Jun 30, 2024 | 11,845.76 |
| Mar 31, 2024 | 3.69 Mn |
| Mar 31, 2024 | 3.69 Mn |
| Dec 31, 2023 | -1.52 Mn |
| Dec 31, 2023 | -1.52 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Sep 30, 2023 | 4.61 Mn |